| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |